Steroidal vs nonsteroidal aromatase inhibitors

Register for alerts
If you have registered for alerts, you should use your registered email address as your username

  • Citation tools Download this article to citation manager Trelle Sven , Reichenbach Stephan , Wandel Simon , Hildebrand Pius , Tschannen Beatrice , Villiger Peter M et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis BMJ 2011; 342 :c7086
    • BibTeX (win & mac) Download
    • EndNote (tagged) Download
    • EndNote 8 (xml) Download
    • RefWorks Tagged (win & mac) Download
    • RIS (win only) Download
    • Medlars Download
    Help If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

    Research on whether NSAIDs contribute to IBD symptoms is conflicting, creating a controversy on their use among gastroenterologists. For the class of drugs called COX-2 inhibitors, there is currently not a lot of evidence in its effects on people with IBD. Some research shows that NSAIDs may affect only a certain percentage of people with IBD, but it's impossible to know who is going to be affected and who is not. It's been speculated that using a COX-2 inhibitor, rather than a drug that is both a COX-1 and a COX-2 inhibitor, might be used with caution in those whose IBD was in remission. 

    Register for alerts
    If you have registered for alerts, you should use your registered email address as your username

  • Citation tools Download this article to citation manager Arfè Andrea , Scotti Lorenza , Varas-Lorenzo Cristina , Nicotra Federica , Zambon Antonella , Kollhorst Bianca et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study BMJ 2016; 354 :i4857
    • BibTeX (win & mac) Download
    • EndNote (tagged) Download
    • EndNote 8 (xml) Download
    • RefWorks Tagged (win & mac) Download
    • RIS (win only) Download
    • Medlars Download
    Help If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

    In the past several years, some newer medications have come on the market; these are commonly referred to as COX-2 inhibitors . Remember, all NSAIDs work against cyclooxygenase (COX). Traditional NSAIDs (. Ibuprofen, Motrin, Aleve) work against both COX-1 and COX-2. COX-1 and COX-2 are both types of cyclooxygenase enzymes that function in your body. The new medications (. Celebrex) work primarily against COX-2, and allow COX-1 to function normally. Because COX-1 is more important in producing the protective lining in your gut (gastric mucosa), these newer NSAIDs are believed to have less of a risk of causing stomach ulcers.

    Steroidal vs nonsteroidal aromatase inhibitors

    steroidal vs nonsteroidal aromatase inhibitors

    In the past several years, some newer medications have come on the market; these are commonly referred to as COX-2 inhibitors . Remember, all NSAIDs work against cyclooxygenase (COX). Traditional NSAIDs (. Ibuprofen, Motrin, Aleve) work against both COX-1 and COX-2. COX-1 and COX-2 are both types of cyclooxygenase enzymes that function in your body. The new medications (. Celebrex) work primarily against COX-2, and allow COX-1 to function normally. Because COX-1 is more important in producing the protective lining in your gut (gastric mucosa), these newer NSAIDs are believed to have less of a risk of causing stomach ulcers.

    Media:

    steroidal vs nonsteroidal aromatase inhibitorssteroidal vs nonsteroidal aromatase inhibitorssteroidal vs nonsteroidal aromatase inhibitorssteroidal vs nonsteroidal aromatase inhibitorssteroidal vs nonsteroidal aromatase inhibitors

  • http://buy-steroids.org